403
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

U.S. Survey of factors associated with adherence to standard of care in treating pregnant women with opioid use disorder

ORCID Icon &
Pages 74-81 | Received 05 Mar 2019, Accepted 15 Jun 2019, Published online: 27 Jun 2019

References

  • Haight SC, Ko JY, Tong VT, et al. Opioid use disorder documented at delivery hospitalization—United States, 1999–2014. MMWR Morb Mortal Wkly Rep. 2018;67:845.
  • Maeda A, Bateman BT, Clancy CR, et al. Opioid abuse and dependence during pregnancy. Anesthesiology. 2014;121:1158–1165.
  • Substance Abuse and Mental Health Services Administration. Center for behavioral health statistics and quality. National survey on drug use and health: detailed tables. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2017. [cited 2018 Nov 1]. Available from: https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf
  • Staudt M. Best practices for enhancing substance abuse treatment retention by pregnant women. Best Pract Ment Health. 2018;14:48–63.
  • National Institutes of Health Consensus Development Panel. Effective medical treatment of opiate addiction. J Med Assoc. 1998;280:1936–1943.
  • Center for Substance Abuse Treatment. MAT for opioid addiction in opioid treatment programs. (Treatment improvement protocol series 43). Rockville (MD): U.S. Department of Health and Human Services; 2005.
  • Cleary B, Donnelly J, Strawbridge J, et al. Methadone and perinatal outcomes: a retrospective cohort study. Am J Obstet Gynecol. 2011;204:139 e1–9.
  • Dashe J, Jackson G, Olscher D, et al. Opioid detoxification in pregnancy. Obstet Gynecol. 1998;92:854–858.
  • Luty J, Nikolaou V, Bearn J. Is opiate detoxification unsafe in pregnancy? J Subst Abuse Treat. 2003;24:363–367.
  • ACOG. ACOG statement on opioid use during pregnancy. The American college of obstetricians and gynecologists; 2016. [cited 2018 Nov 17]. Available from: https://www.acog.org/About-ACOG/News-Room/Statements/2016/ACOG-Statement-on-Opioid-Use-During-Pregnancy.
  • U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. New treatment guidance issued for pregnant and parenting mothers with opioid use disorder and their infants. 2018. [cited Nov 17, 2018]. Available from: https://www.samhsa.gov/newsroom/press-announcements/201802070200.
  • American Society of Addictive Medicine. The national practice guideline for the use of medications in the treatment of addiction involving opioid use. Chevy Chase (MD): American Society of Addictive Medicine; 2015.
  • (a) Minozzi S, Amato L, Vecchi S, et al. Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database Syst Rev. 2008;2:CD006318. (b) Angelotta C, Weiss CJ, Angelotta JW, et al. A moral or medical problem? The relationship between legal penalties and treatment practices for opioid use disorders in pregnant women. J Womens Health. 2016;26:595–601.
  • Jones HE, Finnegan LP, Kaltenbach K. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs. 2012;72:747–757.
  • Dacharme L. State policies and adoption of buprenorphine: summary results of telephone interviews with state agency staff. 2007. [cited 2018 Nov 1]. Available from: https://docplayer.net/6185262-State-policies-and-adoption-of-buprenorphine-summary-results-of-telephone-interviews-with-state-agency-staff.html.
  • Pritham U, Troese M, Stetson A. Methone and buprenorphine: treatment during pregnancy. Nurs Womens Health. 2007;11:560–567.
  • Sander S, Hays LR. Prescription opioid dependence and treatment with methadone in pregnancy. J Opioid Manag. 2005;1:91–97.
  • Jones HE, Terplan M, Meyer M. Medically assisted withdrawal (detoxification): considering the mother–infant dyad. J Addict Med. 2017;11:90–92.
  • American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics. 1998;101:1079–1088.
  • Kellogg A, Rose C, Harms R, et al. Current trends in narcotic use in pregnancy and neonatal outcomes. Am J Obstet Gynecol. 2011;204:259 e1–e4.
  • Volkow ND. Opioids in pregnancy. BMJ. 2016;352:i19.
  • Patrick SW, Faherty LJ, Dick AW, et al. Association among county-level economic factors, clinician supply, metropolitan or rural location, and neonatal abstinence syndrome. JAMA. 2019;321:385–393.
  • Ko JY, Patrick SW, Tong VT, et al. Incidence of neonatal abstinence syndrome—28 states, 1999-2013. Morb Mortal Wkly Rep. 2016;65:799–802.
  • Doberczak T, Kandall S, Friedmann P. Relationships between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal. Obstet Gynecol. 1993;81:936–940.
  • Jones H. Benefits of keeping mom on methadone outweigh risks to baby. Alcohol Drug Abuse Wkly. 2010;10:3–4.
  • Patrick S, Schumacher R, Benneyworth B, et al. Neonatal abstinence syndrome and associated health care expenditures. JAMA. 2012;307:1934–1940.
  • Cicero TJ, Ellis MS, Surratt HL, et al. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71:821–826.
  • Jacewicz N. Teaching future doctors about addiction. Kaiser Health News website; 2016. [Accessed 2019 May 15]. https://khn.org/news/teaching-future-doctors-about-addiction/.
  • Guy GP, Zhang K, Bohm MK, et al. Vital signs: changes in opioid prescribing in the United States, 2006–2015. Morb Mortal Wkly Rep. 2017;66:697–704.
  • American College of Obstetricians and Gynecologists.Committee. Opinion no. 633: alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice. Obstet Gyneco. 2015;125(6);1529–1537.
  • Krans EE, Moloci NM, Housey MT, et al. Impact of psychosocial risk factors on prenatal care delivery: a national provider survey. Matern Child Health J. 2014;18:2362–2370.
  • West C, Graham L, Palmer RT, et al. Implementation of interprofessional education (IPE) in 16 U.S. medical schools: common practices, barriers and facilitators. J Interprof Educ Pract. 2016;4:41–49.
  • Howard H, Clark K. Interprofessional-shared decision making for pregnant women with opioid use: results from a provider training. Curr Wom Health Rev. 2017;13:121–129.
  • Anderson B, Peters E, Fialkow M, et al. Obstetrician-gynecologists’ opinions about the Affordable Care Act and their expectations about how it will affect their practice. Prev Med. 2017;7:216–220.
  • Dotters-Katz S, Smid M, McElwain C, et al. Obstetric practice patterns in pregnancies complicated by fetal trisomy 13 or 18. J Matern-Fetal Neo M. 2017;31:1–10.
  • Fialkow M, Snead C, Schulkin J. New partner recruitment to rural vs. urban ob-gyn practices: a survey of practicing ob-gyns. Health Serv Res Manag Epidemiol. 2017;4:1–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.